PANCREAS NEWS

 

 

J Gastroenterol 2000; 35:136-41.

Nationwide epidemiological survey of chronic pancreatitis in Japan

Lin Y, Tamakoshi A, Matsuno S, Takeda K, Hayakawa T, Kitagawa M, Naruse S, Kawamura T, Wakai K, Aoki R, Kojima M, Ohno Y

Department of Preventive Medicine, Nagoya University School of Medicine. Nagoya, Japan  

JOP expert comment (R Pezzilli: pezzilli@orsola-malpighi.med.unibo.it)

The authors have estimated the number of patients treated for chronic pancreatitis in 1994 in Japan and have explored the clinical and epidemiological features of the disease.

The number of patients with chronic pancreatitis treated in 1994 in Japan was estimated as 32,000, with an overall prevalence rate of 45.4 per 100,000 population in males and 12.4 in females. Alcoholic pancreatitis was the most common type in males (68.5%), and idiopathic pancreatitis in females (69.6%). Compared to the findings in a previous Japanese survey carried-out in 1985, the proportion of idiopathic chronic pancreatitis increased in both males and females. Patients diagnosed using advanced techniques such as computed tomography and endoscopic retrograde cholangiopancreatography accounted for 68.1% of the total.

This is one of the few studies on the prevalence of chronic pancreatitis. It is of great importance that other similar studies be carried out in Western countries in order to better understand the real prevalence and incidence of the disease and the exact role of new genetic and radiological techniques in defining the etiology and in assessing the diagnosis of the disease especially in those patients defined as having an idiopathic pancreatitis.

 

 

Am J Gastroenterol 2000; 95:441-5

Outcome after surgical resection of intraductal papillary and mucinous tumors of the pancreas

Cuillerier E, Cellier C, Palazzo L, Deviere J, Wind P, Rickaert F, Cugnenc PH, Cremer M, Barbier JP

Department of Gastroenterology, Laennec Hospital. Paris, France

JOP expert comment (G Uomo: uomogir@libero.it)

In this study, the authors report the data of a study carried out to evaluate the risk of recurrence in 45 patients with intraductal papillary and mucinous tumors of the pancreas (IPMT) after surgery according to the histological nature of the neoplasm and the type of surgery.

The overall 3-yr actuarial survival rate was 83%. Death occurred in 35% of patients with invasive carcinoma and in 4% of patients with noninvasive tumors (p<0.05). In patients with invasive carcinoma, total pancreatectomy and the absence of lymph node involvement were independently associated with a low risk of recurrence. On the basis of these results the authors concluded that in patients with noninvasive neoplasms, partial pancreatic resection should be guided by frozen section examination until disease-free margins are obtained; and in patients with invasive carcinoma, total pancreatectomy seems the most likely means of curing the patient.

Even if the number of patients studied for the purpose of obtaining definitive results on this topic is not numerous, a multicenter study on a larger number of patients with IPMT in order to confirm these results would be welcome. Furthermore more attention should be paid to the quality of the life of patients operated on. In fact, the social costs are at present an important variable of these types of study.